Navigation Links
Wisconsin publicly traded biomedical companies report gains this quarter

Wisconsin's biotechnology industry has continued its growth, with three publicly traded biotech and health-care companies showing an improvement in revenues and net income over the last quarter. Due to new products and investments, the companies have been able to secure a foothold on the industry.

Bone Care: $1.2 million, boosted by doubled Hectorol sales


Middleton-based pharmaceu......

Full article >>> he third quarter. This is an increase over the same time in 2003, where revenue was $9.4 million and the company was facing a net loss of $1.4 million. Gross margins have improved by 65 percent from last year, and the cash balance at the end of the quarter has gone up to $67.1 million, up $9.3 million from 2003.

The company reported several changes in management. David Nuti, the chief fin......

Full article >>> r. Deferred revenue has also increased, going up 46 percent to reach a total of $5.4 million.

Merge credited the success in profits to the success of its business workflow systems RIS and PACS, which have enjoyed success in imaging centers and specialty clinics. Over the quarter, Merge has signed 19 new contracts for its Fusion line of systems, expanding the company's reach to 366 healthc......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 10/27/04


Related biology technology :

1. To be a player in the "Knowledge Economy," Wisconsin needs more tech workers
2. Federal bioenergy lab will give Wisconsin a chance to shine
3. Breaking down Wisconsins angel capital numbers
4. Innovation featured in NE Wisconsin Roundtable
5. Visions: Broderick says Wisconsin should be in top third in venture capital
6. Wisconsin building toward the major leagues of venture capital
7. Wisconsin Supreme Court to hear Menasha software case
8. Wisconsin applicants urged to pursue DOE funding for cellulosic biomass
9. Legislature should look to Wisconsins natural energy advantages
10. Stem cells get most attention, but they are only part of Wisconsins bio-portfolio
11. BIO 2007: Wisconsin makes its presence felt
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/11/2017)... (PRWEB) , ... October 11, 2017 , ... ... Administration (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal ... the treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... 13 prestigious awards honoring scientists who have made outstanding contributions ... scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for laboratory ...
(Date:10/9/2017)... (PRWEB) , ... October 09, 2017 , ... ... a four-tiered line of medical marijuana products targeting the needs of consumers who ... packaging of Kindred takes place in Phoenix, Arizona. , As operators of two ...
Breaking Biology Technology:
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
Breaking Biology News(10 mins):